Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.680
+0.110 (4.28%)
Jun 2, 2026, 2:48 PM EDT - Market open
Fortress Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 128.94 | -32.92 | -120.86 | -154.15 | -213.91 | -164.83 |
Depreciation & Amortization | 6.63 | 6.6 | 7.31 | 8.08 | 9.35 | 4.32 |
Stock-Based Compensation | 24.21 | 28.74 | 32.62 | 17.03 | 22.99 | 19.49 |
Other Adjustments | -6.47 | -43.11 | 8.86 | 13.34 | 2.89 | -11.89 |
Change in Receivables | -6.8 | -19.33 | 4.47 | 12.52 | -4.84 | 0.83 |
Changes in Inventories | 3.2 | 4.81 | -4.23 | 3.95 | 1.74 | -8.46 |
Changes in Accounts Payable | 36.72 | -7.97 | -6.39 | -24.38 | 8.35 | 43.31 |
Changes in Income Taxes Payable | 4.47 | -0.58 | 0.09 | 0.12 | 0.38 | 0.35 |
Changes in Unearned Revenue | - | - | - | - | -1.88 | 2.61 |
Changes in Other Operating Activities | -4.62 | -2.03 | -2.07 | -4.73 | -4.46 | -2.27 |
Operating Cash Flow | 157.64 | -65.78 | -80.19 | -128.23 | -179.4 | -116.54 |
Capital Expenditures | - | - | - | -0.06 | -2.72 | -4.57 |
Sale of Property, Plant & Equipment | - | 1.17 | - | 6 | 0.13 | - |
Purchases of Intangible Assets | - | - | -15 | -8.04 | -0.34 | -11.78 |
Payments for Business Acquisitions | - | - | - | - | -20 | - |
Proceeds from Business Divestments | - | - | - | - | - | 56.86 |
Other Investing Activities | 5.91 | 8.96 | - | -0.01 | - | - |
Investing Cash Flow | 8.96 | 10.12 | -15 | -2.1 | -22.93 | 40.51 |
Short-Term Debt Issued | - | - | - | 28 | 5 | 7 |
Short-Term Debt Repaid | - | - | - | -30.95 | -2.86 | -6.19 |
Net Short-Term Debt Issued (Repaid) | - | - | - | -2.95 | 2.14 | 0.81 |
Long-Term Debt Issued | 0.06 | -0.08 | 43.67 | 14.53 | 47.11 | - |
Long-Term Debt Repaid | -20.06 | -5.56 | -51 | -50.38 | - | -10.45 |
Net Long-Term Debt Issued (Repaid) | -20 | -5.64 | -7.33 | -35.85 | 47.11 | -10.45 |
Issuance of Common Stock | 3.84 | 3.74 | 21.42 | 24.5 | 6.64 | 9.36 |
Net Common Stock Issued (Repurchased) | 3.84 | 3.74 | 21.42 | 24.5 | 6.64 | 9.36 |
Repurchase of Preferred Stock | -14.45 | -0.27 | - | -0.4 | 17.84 | - |
Net Preferred Stock Issued (Repurchased) | -14.45 | -0.27 | - | -0.4 | 17.84 | - |
Common Dividends Paid | -0.5 | -0.66 | -0.69 | -0.74 | -0.09 | -0.75 |
Preferred Share Dividends Paid | - | - | -4.02 | -8.03 | -8.03 | -8.03 |
Other Financing Activities | 29.15 | 80.27 | 61.26 | 56.2 | 9.92 | 158.05 |
Financing Cash Flow | -2.09 | 77.44 | 70.64 | 32.74 | 75.32 | 148.99 |
Net Cash Flow | 164.5 | 21.79 | -24.55 | -97.59 | -127.01 | 72.97 |
Free Cash Flow | 157.64 | -65.78 | -80.19 | -128.29 | -182.12 | -121.11 |
FCF Margin | 238.26% | -103.98% | -139.04% | -151.80% | -240.44% | -176.05% |
Free Cash Flow Per Share | 5.22 | -2.36 | -3.86 | -15.82 | -30.74 | -22.23 |
Levered Free Cash Flow | 151.79 | -6.68 | -68.51 | -124.49 | -34.6 | -39.05 |
Unlevered Free Cash Flow | -7.74 | -68.09 | -115.95 | -159.85 | -193.23 | -153.79 |